Activating Transcription Factor 3 Regulates in Part the Enhanced Tumour Cell Cytotoxicity of the Histone Deacetylase Inhibitor M344 and Cisplatin in Combination

Cancer Cell International- United Kingdom

doi 10.1186/1475-2867-10-32

Full Text

Abstract

Available in

Date

January 1, 2010

Authors

Carly St Germain

Anna O'Brien

Jim Dimitroulakos

Publisher

Springer Science and Business Media LLC

Related search

The Transcription Factor Erg Regulates Expression of Histone Deacetylase 6 and Multiple Pathways Involved in Endothelial Cell Migration and Angiogenesis

English

Activating Transcription Factor 3 Regulates Canonical TGFβ Signalling in Systemic Sclerosis

Annals of the Rheumatic Diseases

English

Activated Transcription Factor 3 in Association With Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression

Molecular and Cellular Biology

Cell Biology

Molecular Biology

2016

English

The Histone Deacetylase Inhibitor SAHA Arrests Cancer Cell Growth, Up-Regulates Thioredoxin-Binding Protein-2, and Down-Regulates Thioredoxin

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2002

English

486 Histone Deacetylase 3 Regulates the Ontogeny and Maintenance of Tissue-Resident Macrophages

Journal of Investigative Dermatology

English

Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824

Cancer Research

Oncology

2009

English

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

English

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 Against Human Acute Myelogenous Leukemia Cells With Mutant FLT-3

Clinical Cancer Research

Cancer Research

Oncology

2004

English

Enhanced Cisplatin Response With Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line

Turkiye Klinikleri Journal of Medical Sciences

Medicine

2013

English

Amanote Research

Activating Transcription Factor 3 Regulates in Part the Enhanced Tumour Cell Cytotoxicity of the Histone Deacetylase Inhibitor M344 and Cisplatin in Combination

Cancer Cell International- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

The Transcription Factor Erg Regulates Expression of Histone Deacetylase 6 and Multiple Pathways Involved in Endothelial Cell Migration and Angiogenesis

Activating Transcription Factor 3 Regulates Canonical TGFβ Signalling in Systemic Sclerosis

Activated Transcription Factor 3 in Association With Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression

The Histone Deacetylase Inhibitor SAHA Arrests Cancer Cell Growth, Up-Regulates Thioredoxin-Binding Protein-2, and Down-Regulates Thioredoxin

486 Histone Deacetylase 3 Regulates the Ontogeny and Maintenance of Tissue-Resident Macrophages

Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 Against Human Acute Myelogenous Leukemia Cells With Mutant FLT-3

Enhanced Cisplatin Response With Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line